Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

telos rx vs Effecty

telos rx
Graded #15

Higher grade

vs+1
Effecty
Graded #16

Lower grade

The verdict

telos rx takes it — 85/100 to 84/100, but only just.

telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan. Effecty is close behind and may still be the better fit — see the factor split below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuetelos rx +7
87
80
Dose & formulationtelos rx +6
90
84
Clinical oversightEffecty +1
84
85
Labs & monitoringEffecty +4
80
84
FulfillmentEven
87
87
Contract termsEffecty +6
80
86
telos rx · left barEffecty · right bar

The numbers

Metrictelos rxEffecty
WeighScore85/10084/100
GradeBB
Scorecard rank#15#16
SemaglutideFrom $49/mo (annual)$160/mo
Tirzepatide$99/mo (annual)$240/mo
CoverageNot publicly listedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
telos rx

Graded #15 · B

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence
Effecty

Graded #16 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

Where it loses points

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard